MyFinsight
Home
Blog
About
Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals, Inc. (SNOA)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
298.66%
Quick Ratio
229.15%
Cash Ratio
98.00%
Debt to Asset Ratio
63.58%
Unit: Thousand (K) dollars
Assets Breakdown
Cash and cash equivalents
Prepaid expenses and other curre...
Accounts receivable, net
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Withholding tax payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
5,338
2,399
2,561
3,035
Accounts receivable, net
3,182
2,527
2,382
2,703
Inventories, net
3,786
3,651
3,703
3,634
Prepaid expenses and other current assets
3,962
3,436
3,351
2,925
Current portion of deferred consideration, net of discount
-
87
148
204
Total current assets
16,268
12,100
12,145
12,501
Property and equipment, net
290
310
314
284
Operating lease, right of use assets
578
602
642
479
Deferred tax asset, net
905
884
458
508
Deferred consideration, net of discount, less current portion
-
0
0
0
Other assets
66
64
64
84
Total assets
18,107
13,960
13,623
13,856
Accounts payable
2,191
1,923
1,646
1,404
Accrued expenses and other current liabilities
2,674
2,252
2,111
2,024
Deferred revenue
282
284
314
750
Short-term debt
140
222
0
56
Operating lease liabilities, current portion
160
151
146
88
Total current liabilities
5,447
4,832
4,217
4,322
Deferred revenue, net of current portion
-
0
0
0
Withholding tax payable
5,627
5,564
5,465
5,356
Operating lease liabilities, less current portion
439
469
509
391
Total liabilities
11,513
10,865
10,191
10,069
Additional paid-in capital
210,913
207,319
207,023
206,733
Accumulated deficit
-201,311
-200,981
-200,400
-199,581
Accumulated other comprehensive loss
-3,008
-3,243
-3,191
-3,365
Total stockholders equity
6,594
3,095
3,432
3,787
Total liabilities and stockholders equity
18,107
13,960
13,623
13,856
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Cash and cash
equivalents
$5,338K
(48.07%↑ Y/Y)
Prepaid expenses and
other current assets
$3,962K
(38.15%↑ Y/Y)
Inventories, net
$3,786K
(-0.42%↓ Y/Y)
Accounts receivable, net
$3,182K
(22.29%↑ Y/Y)
Total current assets
$16,268K
(24.12%↑ Y/Y)
Deferred tax asset, net
$905K
(65.75%↑ Y/Y)
Operating lease, right of
use assets
$578K
(7.84%↑ Y/Y)
Property and equipment,
net
$290K
(-3.65%↓ Y/Y)
Other assets
$66K
(-17.50%↓ Y/Y)
Total assets
$18,107K
(24.07%↑ Y/Y)
Total liabilities and
stockholders equity
$18,107K
(24.07%↑ Y/Y)
Total liabilities
$11,513K
(9.25%↑ Y/Y)
Total stockholders
equity
$6,594K
(62.57%↑ Y/Y)
Accumulated deficit
-$201,311K
(-1.14%↓ Y/Y)
Accumulated other
comprehensive loss
-$3,008K
(15.74%↑ Y/Y)
Withholding tax payable
$5,627K
(7.26%↑ Y/Y)
Total current
liabilities
$5,447K
(12.36%↑ Y/Y)
Operating lease
liabilities, less current...
$439K
(-0.23%↓ Y/Y)
Additional paid-in capital
$210,913K
(2.05%↑ Y/Y)
Accrued expenses and
other current...
$2,674K
(45.64%↑ Y/Y)
Accounts payable
$2,191K
(7.09%↑ Y/Y)
Deferred revenue
$282K
(-61.42%↓ Y/Y)
Operating lease
liabilities, current portion
$160K
(66.67%↑ Y/Y)
Short-term debt
$140K
(0.72%↑ Y/Y)
Buy us a coffee